Header Logo

Connection

William Hildebrand to Humans

This is a "connection" page, showing publications William Hildebrand has written about Humans.
Connection Strength

0.970
  1. A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer. Oncoimmunology. 2020; 9(1):1685300.
    View in: PubMed
    Score: 0.039
  2. NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors. Cancer Immunol Res. 2018 06; 6(6):636-644.
    View in: PubMed
    Score: 0.035
  3. Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late. J Immunol. 2016 05 15; 196(10):4263-73.
    View in: PubMed
    Score: 0.030
  4. Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove. Elife. 2016 Jan 29; 5.
    View in: PubMed
    Score: 0.030
  5. Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Mol Cancer Ther. 2016 Feb; 15(2):313-22.
    View in: PubMed
    Score: 0.030
  6. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. J Virol. 2014 Nov; 88(22):12992-3004.
    View in: PubMed
    Score: 0.027
  7. Profiling antibodies to class II HLA in transplant patient sera. Hum Immunol. 2014 Mar; 75(3):261-70.
    View in: PubMed
    Score: 0.026
  8. Identification of class I HLA T cell control epitopes for West Nile virus. PLoS One. 2013; 8(6):e66298.
    View in: PubMed
    Score: 0.025
  9. Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol. 2011 Oct-Dec; 30(5-6):312-27.
    View in: PubMed
    Score: 0.022
  10. TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol. 2011 Oct-Dec; 30(5-6):328-40.
    View in: PubMed
    Score: 0.022
  11. HLA class I molecules reflect an altered host proteome after influenza virus infection. Hum Immunol. 2010 Jan; 71(1):14-22.
    View in: PubMed
    Score: 0.020
  12. Determination of cellular lipids bound to human CD1d molecules. PLoS One. 2009; 4(5):e5325.
    View in: PubMed
    Score: 0.019
  13. HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci U S A. 2009 Jan 13; 106(2):540-5.
    View in: PubMed
    Score: 0.018
  14. Identification of breast cancer peptide epitopes presented by HLA-A*0201. J Proteome Res. 2008 Apr; 7(4):1445-57.
    View in: PubMed
    Score: 0.017
  15. Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes. Proc Natl Acad Sci U S A. 2008 Feb 26; 105(8):2981-6.
    View in: PubMed
    Score: 0.017
  16. Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics. 2006 Dec; 3(6):641-52.
    View in: PubMed
    Score: 0.016
  17. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods. 2007 Jan 10; 318(1-2):47-58.
    View in: PubMed
    Score: 0.016
  18. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. Biochemistry. 2005 Sep 20; 44(37):12491-507.
    View in: PubMed
    Score: 0.015
  19. Rhesus macaque MHC class I molecules present HLA-B-like peptides. J Immunol. 2005 Jul 01; 175(1):367-75.
    View in: PubMed
    Score: 0.014
  20. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry. 2004 Nov 23; 43(46):14852-63.
    View in: PubMed
    Score: 0.014
  21. The immune response under stress: the role of HSP-derived peptides. Trends Immunol. 2004 Aug; 25(8):427-33.
    View in: PubMed
    Score: 0.013
  22. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J Immunol. 2004 Mar 01; 172(5):2944-52.
    View in: PubMed
    Score: 0.013
  23. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Sci Adv. 2023 11 24; 9(47):eadj6367.
    View in: PubMed
    Score: 0.013
  24. Cutting edge: class I presentation of host peptides following HIV infection. J Immunol. 2003 Jul 01; 171(1):22-6.
    View in: PubMed
    Score: 0.012
  25. Population of the HLA ligand database. Tissue Antigens. 2003 Jan; 61(1):12-9.
    View in: PubMed
    Score: 0.012
  26. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Hum Immunol. 2002 Apr; 63(4):248-55.
    View in: PubMed
    Score: 0.011
  27. Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor. Immunol Res. 2022 06; 70(3):371-391.
    View in: PubMed
    Score: 0.011
  28. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Front Immunol. 2022; 13:835454.
    View in: PubMed
    Score: 0.011
  29. Sequence-based typing of HLA class I alleles in Alaskan Yupik Eskimo. Hum Immunol. 2001 Jun; 62(6):639-44.
    View in: PubMed
    Score: 0.011
  30. Class I MHC expression in the yellow baboon. J Immunol. 2001 Mar 15; 166(6):3983-93.
    View in: PubMed
    Score: 0.011
  31. Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides. Front Immunol. 2020; 11:629399.
    View in: PubMed
    Score: 0.011
  32. Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules. Tissue Antigens. 2001 Feb; 57(2):95-102.
    View in: PubMed
    Score: 0.011
  33. Precision genotyping of human leukocyte antigen-A, -B and -C loci via direct DNA sequencing. Methods Mol Biol. 2001; 156:129-42.
    View in: PubMed
    Score: 0.010
  34. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells. Hum Immunol. 2000 Dec; 61(12):1339-46.
    View in: PubMed
    Score: 0.010
  35. Determinants governing T cell receptor a/ß-chain pairing in repertoire formation of identical twins. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):532-540.
    View in: PubMed
    Score: 0.010
  36. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23662-23670.
    View in: PubMed
    Score: 0.010
  37. Alpha-2 domain polymorphism and HLA class I peptide loading. Tissue Antigens. 1999 Nov; 54(5):450-60.
    View in: PubMed
    Score: 0.010
  38. Precision mouse models with expanded tropism for human pathogens. Nat Biotechnol. 2019 10; 37(10):1163-1173.
    View in: PubMed
    Score: 0.010
  39. HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol. 1999 Jun 15; 162(12):7277-84.
    View in: PubMed
    Score: 0.009
  40. Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic Donors. Front Immunol. 2019; 10:313.
    View in: PubMed
    Score: 0.009
  41. Peptide motif of the class I molecule HLA-B*1503. Immunogenetics. 1999 Feb; 49(2):144-6.
    View in: PubMed
    Score: 0.009
  42. Sequence-based typing provides a new look at HLA-C diversity. J Immunol. 1998 Aug 01; 161(3):1406-13.
    View in: PubMed
    Score: 0.009
  43. Role of MAIT cells in pulmonary bacterial infection. Mol Immunol. 2018 09; 101:155-159.
    View in: PubMed
    Score: 0.009
  44. Urinary Peptides As a Novel Source of T Cell Allergen Epitopes. Front Immunol. 2018; 9:886.
    View in: PubMed
    Score: 0.009
  45. T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells. PLoS One. 2017; 12(11):e0188288.
    View in: PubMed
    Score: 0.008
  46. MHC-I Genotype Restricts the Oncogenic Mutational Landscape. Cell. 2017 Nov 30; 171(6):1272-1283.e15.
    View in: PubMed
    Score: 0.008
  47. T cells from patients with Parkinson's disease recognize a-synuclein peptides. Nature. 2017 06 29; 546(7660):656-661.
    View in: PubMed
    Score: 0.008
  48. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017 06 20; 46(6):1018-1029.e7.
    View in: PubMed
    Score: 0.008
  49. Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine. 1997 Jun; 15(8):903-8.
    View in: PubMed
    Score: 0.008
  50. Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304. Hum Immunol. 1997 Jun; 55(1):66-73.
    View in: PubMed
    Score: 0.008
  51. The Intergenic Recombinant HLA-B*46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Rep. 2017 05 16; 19(7):1394-1405.
    View in: PubMed
    Score: 0.008
  52. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics. 1997; 45(6):379-85.
    View in: PubMed
    Score: 0.008
  53. Description of a modified sequencing strategy and the molecular characterization of HLA-B*8201. Tissue Antigens. 1996 May; 47(5):438-41.
    View in: PubMed
    Score: 0.008
  54. Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation. Transplantation. 1996 Apr 15; 61(7):989-96.
    View in: PubMed
    Score: 0.008
  55. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference. J Immunol. 2016 Feb 15; 196(4):1480-7.
    View in: PubMed
    Score: 0.007
  56. Molecular characterization of HLA-A*6803. Immunogenetics. 1996; 45(1):78-9.
    View in: PubMed
    Score: 0.007
  57. Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family. Tissue Antigens. 1996 Jan; 47(1):49-57.
    View in: PubMed
    Score: 0.007
  58. Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection. Infect Immun. 2016 02; 84(2):480-90.
    View in: PubMed
    Score: 0.007
  59. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens. Hum Immunol. 1995 Oct; 44(2):103-10.
    View in: PubMed
    Score: 0.007
  60. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15; 348(6236):803-8.
    View in: PubMed
    Score: 0.007
  61. The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression. AIDS. 2015 Mar 13; 29(5):507-17.
    View in: PubMed
    Score: 0.007
  62. HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort. AIDS. 2014 Sep 24; 28(15):2323-5.
    View in: PubMed
    Score: 0.007
  63. Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules. J Virol. 2014 Mar; 88(6):3298-308.
    View in: PubMed
    Score: 0.006
  64. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS. 2012 Jul 17; 26(11):F21-9.
    View in: PubMed
    Score: 0.006
  65. Proteome sampling by the HLA class I antigen processing pathway. PLoS Comput Biol. 2012; 8(5):e1002517.
    View in: PubMed
    Score: 0.006
  66. A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules. Immunogenetics. 2012 Jun; 64(6):421-34.
    View in: PubMed
    Score: 0.006
  67. Definition of the viral targets of protective HIV-1-specific T cell responses. J Transl Med. 2011 Dec 07; 9:208.
    View in: PubMed
    Score: 0.006
  68. A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. PLoS One. 2011; 6(8):e23603.
    View in: PubMed
    Score: 0.005
  69. Differential MHC class I expression in distinct leukocyte subsets. BMC Immunol. 2011 Jul 15; 12:39.
    View in: PubMed
    Score: 0.005
  70. An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011 Jun 01; 186(11):6607-16.
    View in: PubMed
    Score: 0.005
  71. Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. J Immunol. 2011 Feb 01; 186(3):1575-88.
    View in: PubMed
    Score: 0.005
  72. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. PLoS One. 2010 Dec 13; 5(12):e15343.
    View in: PubMed
    Score: 0.005
  73. NIAID workshop on Flavivirus immunity. Viral Immunol. 2010 Jun; 23(3):235-40.
    View in: PubMed
    Score: 0.005
  74. Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity. World J Gastroenterol. 2010 Apr 28; 16(16):1953-69.
    View in: PubMed
    Score: 0.005
  75. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol. 2010 Apr 15; 184(8):4423-30.
    View in: PubMed
    Score: 0.005
  76. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 2009 Oct; 7(10):e1000228.
    View in: PubMed
    Score: 0.005
  77. Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunol Immunother. 2010 Apr; 59(4):563-73.
    View in: PubMed
    Score: 0.005
  78. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol. 2009 Jun 15; 182(12):7763-75.
    View in: PubMed
    Score: 0.005
  79. Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunol Immunother. 2009 Sep; 58(9):1419-31.
    View in: PubMed
    Score: 0.005
  80. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol. 2007 Jan; 68(1):30-40.
    View in: PubMed
    Score: 0.004
  81. Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol. 2006 Oct 15; 177(8):5088-97.
    View in: PubMed
    Score: 0.004
  82. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol. 2005 Oct 15; 175(8):5448-56.
    View in: PubMed
    Score: 0.004
  83. Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. J Virol. 2005 Mar; 79(5):3052-62.
    View in: PubMed
    Score: 0.004
  84. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. J Immunol. 2005 Jan 15; 174(2):962-9.
    View in: PubMed
    Score: 0.003
  85. HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III. Hum Immunol. 2004 Jan; 65(1):78-89.
    View in: PubMed
    Score: 0.003
  86. Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy. J Urol. 2003 Jun; 169(6):2084-8.
    View in: PubMed
    Score: 0.003
  87. Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins. J Infect Dis. 2003 Jan 15; 187(2):315-9.
    View in: PubMed
    Score: 0.003
  88. HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II. Hum Immunol. 2002 Jul; 63(7):614-25.
    View in: PubMed
    Score: 0.003
  89. Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood. 2002 May 01; 99(9):3360-6.
    View in: PubMed
    Score: 0.003
  90. Disparate binding of chaperone proteins by HLA-A subtypes. Immunogenetics. 2002 Feb; 53(10-11):830-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.